Testosterone Cypionate Injection Recalled Due to Sterility Concerns
First Pharma Associates is recalling Testosterone Cypionate 150 mg/mL Injection due to a lack of assurance of sterility. The product was distributed in Idaho and Washington.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of infection or serious injury, meeting the criteria for a Severe rating.
Plain-English summary
First Pharma Associates LLC dba Riverpoint Pharmacy is recalling Testosterone Cypionate 150 mg/mL Sesame Oil Injection, 12 mL vial. The recall was initiated because of a lack of assurance of sterility. The affected product is prescription-only and was distributed in Idaho and Washington.
The specific lot number is 04202019@1, with an expiration date of 07/21/2019. The manufacturer is located in Spokane, WA. No specific illness or injury counts are reported in the source text.
Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Testosterone Cypionate 150 mg/mL Sesame Oil Injection, 12 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343- 6252.
- Category
- Drug — Injectable Steroid
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 04202019@1
- Exp. 07/21/2019
Distribution
Part of a larger recall action
This product is one of 18 recalled by First Pharma Associates LLC dba Riverpoint Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · First Pharma Associates LLC dba Riverpoint Pharmacy
See all →- SevereHydroxocobalamin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-07-17
- SevereMethylcobalamin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-07-17
- HighTestosterone Cypionate Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-07-17
- SevereRiverpoint Pharmacy Recalls Chorionic Gonadotropin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-07-17
- SevereRiverpoint Pharmacy Recalls Testosterone Cyp/Estradiol Cyp Injection Due to Sterility Concerns
FDA (Drugs) · 2019-07-17
Same hazard · sterility
See all →- SevereGood Sense Eye Drops Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-14
- SevereCarolina Infusion Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereCarolina Infusion Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Artificial Tears Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereApothecary NAD+ Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereTestosterone Cypionate Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
- SevereTestosterone Cypionate Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2013-09-18
- SevereEssential Wellness Pharma Recalls Testosterone Cypionate Injections Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereAssurance Infusion Recalls Testosterone Cypionate Injections Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereDowning Labs Recalls Testosterone Cypionate Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- HighFDA Recalls Testosterone Cypionate Injection Vials for Lack of Sterility Assurance
FDA (Drugs) · 2022-06-01